All Pharma News
price-trendAsk Us
PALADIN Releases Playbook & Resource Repository to Support Advocacy Group

PALADIN Releases Playbook & Resource Repository to Support Advocacy Group
PR NEWSWIRE
06 Mar 2024
Share Share
Endo`s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada

Endo`s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
PR NEWSWIRE
22 Jan 2024
Share Share
Health Canada accepts Paladin’s NDS for epilepsy-linked seizure therapy

Health Canada accepts Paladin’s NDS for epilepsy-linked seizure therapy
PHARMACEUTICAL-TECHNOLOGY
09 Aug 2022
Share Share
Paladin Labs Launches of Xydalba (dalbavancin for injection) in Canada

Paladin Labs Launches of Xydalba (dalbavancin for injection) in Canada
YAHOO FINANCE
18 Jan 2022
Share Share
Endo Announces Licensing Agreement for Paladin Labs to Abaloparatide

Endo Announces Licensing Agreement for Paladin Labs to Abaloparatide
PRNEWSWIRE
05 Jan 2021
Share Share
Veloxis & Endo Ventures Jointly Announce Agreement for Paladin Labs Envarsus XR

Veloxis & Endo Ventures Jointly Announce Agreement for Paladin Labs Envarsus XR
PR NEWSWIRE
06 Jun 2017
Share Share
Endo Considers Sale of Paladin Labs to Knight Therapeutics

Endo Considers Sale of Paladin Labs to Knight Therapeutics
John Tilak REUTERS
05 Nov 2016
Share Share
Meet Pharma’s Newest Movers and Shakers

Meet Pharma’s Newest Movers and Shakers
Jonathan D. Rockpff and Joseph Walker THE WALL STREET JOURNAL
25 Apr 2015
Share Share
Endo Said to be Jousting with Valeant, Shire to Win Salix

Endo Said to be Jousting with Valeant, Shire to Win Salix
Carly Helfand FIERCE PHARMA
20 Feb 2015
Share Share